BDK-IN-1 (compound (-)-43) is a BDK inhibitor with the IC50 of 0.23 µM and the max inhibition of 90%. BDK-IN-1 decreases the level of phospho-E1 and can be used for study of cardiometabolic diseases[1].
Molecular Weight:
376.38
Formula:
C18H14F2N2O3S
Target:
Endogenous Metabolite
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
